It's been a very interesting discussion about this particular subject because what the House of Commons voted on in 2014 and what the House of Commons got after 2014 are very different. Industry came to the House of Commons and said that they recommended some type of a risk management measure be developed to eliminate microplastics from cosmetic products specifically. The reason for that was that products coming from China had a particular attribute, which had a great deal of those microplastics, but what happened after the motion was voted on in the House of Commons was that Environment Canada and Health Canada didn't define them as microplastics in cosmetic products. They defined them based on their size, which captured every single polymer of a certain size and below, which was not what the House of Commons voted on, was not the intention of Parliament, and was not what was part of that debate.
What it tells us is that there is a need to reform CEPA to be very clear so that we can have targeted, purposeful listings under the toxic substances list based on use and on the attributes that actually pose the risk in question. When we hear about adding plastics or single-use plastics to the list of toxic substances, when I review the act, I don't think those meet the definition of “substances”, which are the molecules that the chemicals management plan was designed to deal with. Now, for an array of reasons Health Canada, Environment Canada and the Department of Justice don't agree that this is something that can happen right now, so we recommended during the CEPA review—and we would recommend again now—that this would be a reason to amend CEPA to create that specific power.